Utilization of Non-Invasive Respiratory Support in ARDS: Insights on Physiology, Challenges, and Strategies for Effective Implementation

By
Laveena Munshi
Massimo Antonelli
Jean-Pierre Frat
October 7, 2026

Intensive Care Medicine

Overview

Non-invasive ventilation (NIV), continuous positive airway pressure (CPAP), and high-flow nasal cannula (HFNC) are increasingly used in acute hypoxemic respiratory failure and ARDS, but optimal patient selection, device choice, and timing of intubation remain unresolved. Positive pressure can improve oxygenation and reduce respiratory effort, while excessive spontaneous effort and large tidal volumes may contribute to lung injury and treatment failure.

Background

Non-invasive respiratory support use has increased alongside improved interfaces, greater clinician experience, and efforts to avoid complications associated with invasive mechanical ventilation. In the pre-COVID LUNG SAFE study, NIV was used in approximately 15% of patients; subsequent practice has evolved with evidence supporting HFNC and helmet NIV. The 2024 Global Definition of ARDS recognizes patients receiving non-invasive support, although much of the supporting evidence comes from earlier acute hypoxemic respiratory failure populations with varying eligibility criteria. This distinction matters when interpreting study findings and applying them to contemporary ARDS practice.

Data Highlights

Measure or evidence	Finding
NIV use in pre-COVID LUNG SAFE	Approximately 15% of patients
Tidal volume associated with unfavorable outcomes during NIV	Greater than 9 mL/kg predicted body weight
SOHO trial: cumulative intubation by day 28	42.4% with HFNC versus 48.4% with standard oxygen; difference −5.93 percentage points (95% CI, −11.78 to −0.08)
SOHO trial: 28-day mortality	No significant difference between HFNC and standard oxygen
RENOVATE trial	Among 1,766 patients across five prespecified groups, HFNC was noninferior to NIV for intubation or death by day 7 in four groups; the immunocompromised hypoxemia group met a futility boundary

Key Findings

NIV and CPAP improve oxygenation primarily through positive end-expiratory pressure, which increases lung volume and can facilitate alveolar recruitment.
In patients with preserved cardiac function, positive pressure may reduce intrapulmonary shunt through recruitment; substantial reductions in cardiac output may negate the oxygenation benefit.
Pressure support can reduce inspiratory workload and dyspnea, but heightened respiratory drive may produce large pleural-pressure swings and regional lung stress associated with patient self-inflicted lung injury.
During NIV, sustained elevated inspiratory effort measured by esophageal pressure swings has been associated with treatment failure; tidal volumes above 9 mL/kg predicted body weight have been reported in association with unfavorable outcomes.
Helmet NIV allows higher PEEP with minimal air leakage, and asynchronies are typically less clinically consequential than with face masks; effort that does not trigger pressure support still represents work of breathing.
The 2026 American Thoracic Society guideline strongly recommends HFNC over standard oxygen for de novo acute hypoxemic respiratory failure and conditionally recommends NIV or CPAP over standard oxygen. In SOHO, HFNC did not significantly change 28-day mortality but was associated with a lower cumulative intubation rate by day 28; RENOVATE found HFNC noninferior to NIV for its primary composite in four of five patient groups.

Clinical Implications

The source review identifies patient selection, device and interface choice, and timely recognition of non-invasive support failure as unresolved clinical challenges. It also notes that bedside assessment of inspiratory effort and P-SILI risk, including esophageal pressure monitoring, is limited and not routinely performed. The ATS guideline recommendations and trial findings apply to acute respiratory failure populations and should be interpreted in light of the differing populations and definitions represented in the evidence.

Conclusion

Non-invasive support can improve oxygenation and reduce respiratory effort, but excessive spontaneous effort and large tidal volumes remain important physiologic concerns. Current evidence and guidance inform modality selection, while optimal selection and failure-recognition strategies remain unsettled.